Kaiser Family Foundation
The Henry J. Kaiser Family Foundation  
  Home Contact Us Email Subscriptions
Browse By Report Type
Abstract
Previous
Next
Empty Graphic
Employer Health Benefits 2003 Annual Survey
Pages: 1 2 3  < previous | next >
Empty Graphic
Empty Graphic
Empty Graphic
Empty Graphic
 
Prescription Drug Benefits
  • Prescription drugs continue to be a standard benefit provided for covered workers, (99%) (Exhibits 8.2, 8.3). To combat rising prices, firms are increasingly providing employees with financial incentives to encourage use of generic drugs and certain categories of preferred brand name drugs.
    • The use of three-tier cost sharing arrangements, where a worker faces one copay for generic drugs, a higher one for preferred drugs (such as brand name drugs with no generic substitutes), and an even higher one for non-preferred drugs (such as brand named drugs with generic substitutes) has increased over the past year, growing from 55% of covered workers in 2002 to 63% in 2003 (Exhibit 9.1). Over the same time frame, two-tier cost sharing arrangements, where employees face one payment level when purchasing brand name drugs and another when using generic drugs, declined from 30% to 23% of covered workers. The prevalence of plans that charge workers the same amount, regardless of the type of drug purchased, has remained constant.
    • The majority of workers in conventional, HMO, PPO, and POS plans have either a two-tier or three-tier cost sharing formula for prescription drugs. Workers in PPOs are most likely to have a three-tier cost sharing formula (65%).
  • The average copayment requirement for employees when buying a non-preferred drug has risen from $17 in 2000 to $29 in 2003 (Exhibit 9.2).

    • Copays average $9 for generics, $19 for preferred drugs, and $29 for non-preferred drugs, with little variation by plan type. Average copays for non-preferred drugs have increased over the last year, especially in PPO and POS plans. Copays for such drugs remain highest in PPO plans, where they increased from $26 in 2002 to $30 in 2003.
    • For workers with coinsurance rather than copays (between seven and eleven percent of workers, depending on drug type), cost sharing levels average 20% for generic drugs, 24% for preferred drugs, and 29% for non-preferred drugs (Exhibit 9.3).
  • Seventy-one percent of workers are in plans that use a for-mulary that restricts which drugs will be covered, statistically unchanged from 2002 (70%) (Exhibit 9.5).
  • Twenty-eight percent of covered workers are in firms that “carve out” prescription drugs and provide this benefit separately from their standard health plans, a similar percentage to last year.

    • Among these firms, employers reported that prescription costs for family coverage increased 15%.
    • Eight percent of covered workers face a separate deductible for prescription drugs in 2003, and the average deductible has risen from $88 in 2000 to $161 this year.
Empty Graphic
Pages: 1 2 3  < previous | next >
Empty Graphic
Abstract
Previous
Next
Empty Graphic
EMPLOYER HEALTH BENEFITS 2003 ANNUAL SURVEY
The Kaiser Family Foundation and Health Research and Educational Trust
 
Information provided by the Health Care Marketplace Program.
Publication Number 3369.

 

Search kff.org
Search Costs/Insurance Only
Advanced SearchHelp
Search Kff.org  
  Advanced Search Help
Copyright 2012 The Henry J. Kaiser Family Foundation Privacy Policy Help Contact